Skip to main content
TipRanks
Go Ultimate75% OFF

Seelos Therapeutics (SEELQ) Income Statement

1,198 Followers

Seelos Therapeutics Income Statement

Last quarter (Q2 2024), Seelos Therapeutics's total revenue was ―. In Q2, Seelos Therapeutics's net income was $1.71M. See Seelos Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 23Dec 22Dec 21Dec 20Dec 19
―――――
$ 2.20M―――$ 151.00K
―――――
Depreciation and Amortization―――――
$ -37.75M$ -73.47M$ -64.45M$ -18.94M$ -51.23M
$ -40.50M$ -70.92M$ -61.67M$ -18.76M$ -34.99M
―――――
―――――
$ -37.88M$ -73.53M$ -66.05M$ -19.10M$ -51.26M
Per Share Metrics
Basic EPS―――――
Diluted EPS―――――
Weighted Average Shares Outstanding―――――
Weighted Average Shares Outstanding (Diluted)―――――

Currency in USD

Seelos Therapeutics Earnings and Revenue History

-90M-60M-30M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2019202020212022RevenueEarningsProfit Margin